Nishio M - Search Results

1

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.

Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Among authors: nishio m. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.

2

Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer.

Nishio M, Ohyanagi F, Taguch F, Matsuda M, Sato Y, Okumura S, Nakagawa K, Horai T. Nishio M, et al. Lung Cancer. 2005 Apr;48(1):115-9. doi: 10.1016/j.lungcan.2004.09.006. Lung Cancer. 2005. PMID: 15777978 Clinical Trial.

3

Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.

Ohyanagi F, Taguchi F, Horai T, Kasahara K, Takeda Y, Shibata K, Shirosaki H, Nishio M. Ohyanagi F, et al. Among authors: nishio m. Jpn J Clin Oncol. 2006 Sep;36(9):547-51. doi: 10.1093/jjco/hyl062. Epub 2006 Jul 26. Jpn J Clin Oncol. 2006. PMID: 16870693 Clinical Trial.

4

Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.

Nishio M, Taguchi F, Ohyanagi F, Horikike A, Ishikawa Y, Satoh Y, Okumura S, Nakagawa K, Nishio K, Horai T. Nishio M, et al. Among authors: nishio k. Anticancer Res. 2006 Sep-Oct;26(5B):3761-5. Anticancer Res. 2006. PMID: 17094398 Free article.

5

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer.

Ohyanagi F, Horiike A, Okano Y, Satoh Y, Okumura S, Ishikawa Y, Nakagawa K, Horai T, Nishio M. Ohyanagi F, et al. Among authors: nishio m. Cancer Chemother Pharmacol. 2008 Mar;61(3):503-8. doi: 10.1007/s00280-007-0496-6. Epub 2007 May 5. Cancer Chemother Pharmacol. 2008. PMID: 17483949 Clinical Trial.

6

Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer.

Horiike A, Kimura H, Nishio K, Ohyanagi F, Satoh Y, Okumura S, Ishikawa Y, Nakagawa K, Horai T, Nishio M. Horiike A, et al. Among authors: nishio m, nishio k. Chest. 2007 Jun;131(6):1628-34. doi: 10.1378/chest.06-1673. Chest. 2007. PMID: 17565015

7

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Hida T, Tamiya M, Nishio M, Yamamoto N, Hirashima T, Horai T, Tanii H, Shi MM, Kobayashi K, Horio Y. Hida T, et al. Among authors: nishio m. Cancer Sci. 2011 Apr;102(4):845-51. doi: 10.1111/j.1349-7006.2010.01839.x. Epub 2011 Feb 8. Cancer Sci. 2011. PMID: 21205086 Free article. Clinical Trial.

8

Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II study.

Ohyanagi F, Horai T, Sekine I, Yamamoto N, Nakagawa K, Nishio M, Senger S, Morsli N, Tamura T. Ohyanagi F, et al. Among authors: nishio m. Jpn J Clin Oncol. 2011 May;41(5):718-22. doi: 10.1093/jjco/hyr021. Epub 2011 Mar 9. Jpn J Clin Oncol. 2011. PMID: 21393255 Clinical Trial.

9

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.

Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M. Kudo K, et al. Among authors: nishio m. Lung Cancer. 2011 Dec;74(3):401-4. doi: 10.1016/j.lungcan.2011.03.019. Epub 2011 Apr 29. Lung Cancer. 2011. PMID: 21529988

10

Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study).

Imamura F, Nishio M, Noro R, Tsuboi M, Ikeda N, Inoue A, Ohsaki Y, Kimura Y, Nishino K, Uchida J, Horai T. Imamura F, et al. Among authors: nishio m. Chemotherapy. 2011;57(4):357-62. doi: 10.1159/000330481. Epub 2011 Sep 6. Chemotherapy. 2011. PMID: 21912118 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,467 results

Search Page